HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Preliminary results of cord blood mononuclear cell therapy for multiple system atrophy: a report of three cases.

AbstractOBJECTIVES:
This study was designed to evaluate the effects of cord blood mononuclear cell transplantation in multiple system atrophy (MSA).
CLINICAL PRESENTATION AND INTERVENTION:
Cord blood mononuclear cells (1-2 × 10(8) cells/6 ml) were injected into the subarachnoid space using lumbar puncture in patients 1 and 2 and cisterna magna puncture in patient 3 in the 3 patients with MSA. The cord blood mononuclear cell transplantation was repeated 30 days after the first treatment in patients 1 and 2; it was repeated twice in patient 3. The clinical outcomes of treatment were used to assess the Unified Multiple System Atrophy Rating Scale (UMSARS) before, 90 and 180 days after the cell transplantation. There were no clinically noticeable side effects from the cord blood mononuclear cells. The UMSARS scores improved after 90 days of the cord blood mononuclear cell therapy in all 3 patients, the most significant improvement being that in urinary incontinence and ability to walk.
CONCLUSIONS:
Cord blood mononuclear cell transplantation was safe and potentially effective in the treatment of MSA in the 3 patients.
AuthorsShu-Hui Wu, Hai-Xin Yang, Gui-Hua Jiang, Dian-Rong Gong, Le-Xin Wang
JournalMedical principles and practice : international journal of the Kuwait University, Health Science Centre (Med Princ Pract) Vol. 23 Issue 3 Pg. 282-5 ( 2014) ISSN: 1423-0151 [Electronic] Switzerland
PMID23948955 (Publication Type: Case Reports, Journal Article)
Copyright© 2013 S. Karger AG, Basel.
Topics
  • Cell Transplantation (methods)
  • Female
  • Fetal Blood
  • Humans
  • Leukocytes, Mononuclear (transplantation)
  • Male
  • Middle Aged
  • Multiple System Atrophy (blood, therapy)
  • Spinal Puncture

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: